Aggregation‐State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL‐37 and HNP1
Angewandte Chemie International Edition · 11.05.2026 · 65 (20)
DOI: 10.1002/anie.202516436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 02.04.2026. Verfasst von Yuge Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Industrial Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Antimicrobial Cationic Peptides, alpha-Defensins, Antimicrobial Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Science and Technology Agency, New Energy and Industrial Technology Development Organization, HU-RIZON international excellence program call 2024:.
Abstract (Originalsprache)
The double cooperative effect between two major antimicrobial peptides, LL‐37 and HNP1, where their combination enhances antimicrobial efficiency while reducing cytotoxicity, offers a promising strategy for developing safer and more effective antibiotics against antimicrobial resistance. However, the molecular mechanism driving this effect has remained unclear. In this study, a combination of total internal reflection fluorescence (TIRF) microscopy, Förster resonance energy transfer (FRET), nuclear magnetic resonance (NMR), and molecular dynamic simulation (MD) revealed that the double cooperative effect arises from the dynamic assembly and disassembly of LL‐37/HNP1 aggregates, where the degree of aggregation governs membrane toxicity and therefore influences the cell fate. The aggregation is driven primarily through hydrophobic interactions between several amino acids within LL‐37 and HNP1. Interestingly, in membranes, this aggregation state is regulated by the lipid composition, where only anionic lipids can break up the aggregates and disperse peptides in the membranes, leading to the gain of peptides’ function. Taking the advantage of the lipid composition difference, this enables the aggregates to destroy bacterial membranes, whereas protect eukaryotic cell membranes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
- Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan.
- New Industry Creation Hatchery Center, Tohoku University, Sendai, Miyagi, Japan.
- Department of Physics, School of Science, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Pudong District, Shanghai, China.
- Medicinal Chemistry and Bioinformatics Center, Shanghai JiaoTong University, School of Medicine, Shanghai, China.
ORCID-Profile: Kaori Sugihara
Förderung
- Japan Science and Technology Agency
- New Energy and Industrial Technology Development Organization
- HU-RIZON international excellence program call 2024:
- Murata Science Foundation
- Beyond AI
Zitieren
APA
Hou, Y., Zhang, J., Takeuchi, K., Higuchi, H., Kaya, M., Li, R., Zheng, J., Chen, J., Watanabe, G., & Sugihara, K. (2026). Aggregation‐State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL‐37 and HNP1. Angewandte Chemie International Edition, 65(20). https://doi.org/10.1002/anie.202516436
Vancouver
Hou Y, Zhang J, Takeuchi K, Higuchi H, Kaya M, Li R, et al. Aggregation‐State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL‐37 and HNP1. Angewandte Chemie International Edition. 2026;65(20). doi:10.1002/anie.202516436
BibTeX
@article{Hou2026,
author = {Hou, Yuge and Zhang, Jing and Takeuchi, Koh and Higuchi, Hideo and Kaya, Motoshi and Li, Rui and Zheng, Jianlu and Chen, Jiali and Watanabe, Go and Sugihara, Kaori},
title = {Aggregation‐State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL‐37 and HNP1},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {20},
doi = {10.1002/anie.202516436}
}
EUVIMED